China hits back at EU ban with ‘tit-for-tat’ medical device restrictions
China has imposed restrictions on procurement of European medical devices, following a similar move made by the European Union (EU)…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a news and features reporter for Pharmaceutical Technology and Medical Device Network. Robert holds a BSc in Neuroscience and holds interests in neurological devices, infectious diseases, and company investment such as initial public offerings (IPOs). Contact Rob
-
-
Carlsmed targets IPO to continue medtech public listing boom
AI-focused spinal surgery firm Carlsmed is planning to go public, adding to a strong year of medtech initial public offerings…
-
GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion
The US Food and Drug Administration (FDA) has expanded the indications of an imaging agent developed by GE HealthCare, which…
-
TISSIUM wins FDA approval for sutureless nerve repair platform
The US Food and Drug Administration (FDA) has granted de novo marketing authorisation to TISSIUM’s COAPTIUM CONNECT, representing the first…
-
Illumina bets on proteomics with $425m SomaLogic purchase
Illumina has agreed to acquire proteomics specialist SomaLogic in a deal worth up to $425m, bolstering its portfolio amid investor…
-
RFK Jr axes vaccine advisory committee members
The US department of Health and Human Services (HHS) has culled the 17 Biden-appointed members on the Advisory Committee for…
-
What’s been agreed at this year’s World Health Assembly?
With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s…
-
Regeneron buys bankrupt 23andMe for $256m
23andMe has found itself a buyer after biotech Regeneron won an auction to buy the bankrupt genetics company for $256m.…
-
Intravascular lithotripsy: market competition and clinical potential
A large number of eyes could be on a fast-growing technology used to modify plaque in arteries as attendees gather…
-
STAAR Surgical plans $30m share buyback despite China market woes
Shares in STAAR Surgical jumped today (16 May) after the implantable lens developer revealed plans to bring $30m worth of…